The effects of the COVID-19 pandemic on psychological stress in breast cancer patients.
Breast Cancer
COVID-19
Psychological distress
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
31 Dec 2021
31 Dec 2021
Historique:
received:
13
03
2021
accepted:
15
11
2021
entrez:
1
1
2022
pubmed:
2
1
2022
medline:
5
1
2022
Statut:
epublish
Résumé
The majority of breast cancer patients are severely psychologically affected by breast cancer diagnosis and subsequent therapeutic procedures. The COVID-19 pandemic and associated restrictions on public life have additionally caused significant psychological distress for much of the population. It is therefore plausible that breast cancer patients might be particularly susceptible to the additional psychological stress caused by the pandemic, increasing suffering. In this study we therefore aimed to assess the level of psychological distress currently experienced by a defined group of breast cancer patients in our breast cancer centre, compared to distress levels pre-COVID-19 pandemic. Female breast cancer patients of all ages receiving either adjuvant, neoadjuvant, or palliative therapies were recruited for the study. All patients were screened for current or previous COVID-19 infection. The participants completed a self-designed COVID-19 pandemic questionnaire, the Stress and Coping Inventory (SCI), the National Comprehensive Cancer Network® (NCCN®) Distress Thermometer (DT), the European Organization for Research and Treatment of Cancer (EORTC) QLQ C30, and the BR23. Eighty-two breast cancer patients were included. Therapy status and social demographic factors did not have a significant effect on the distress caused by the COVID-19 pandemic. The results of the DT pre and during COVID-19 pandemic did not differ significantly. Using the self-designed COVID-19 pandemic questionnaire, we detected three distinct subgroups demonstrating different levels of concerns in relation to SARS-CoV-2. The subgroup with the highest levels of concern reported significantly decreased life quality, related parameters and symptoms. This monocentric study demonstrated that the COVID-19 pandemic significantly affected psychological health in a subpopulation of breast cancer patients. The application of a self-created "COVID-19 pandemic questionnaire" could potentially be used to help identify breast cancer patients who are susceptible to increased psychological distress due to the COVID-19 pandemic, and therefore may need additional intensive psychological support. DRKS-ID: DRKS00022507 .
Sections du résumé
BACKGROUND
BACKGROUND
The majority of breast cancer patients are severely psychologically affected by breast cancer diagnosis and subsequent therapeutic procedures. The COVID-19 pandemic and associated restrictions on public life have additionally caused significant psychological distress for much of the population. It is therefore plausible that breast cancer patients might be particularly susceptible to the additional psychological stress caused by the pandemic, increasing suffering. In this study we therefore aimed to assess the level of psychological distress currently experienced by a defined group of breast cancer patients in our breast cancer centre, compared to distress levels pre-COVID-19 pandemic.
METHODS
METHODS
Female breast cancer patients of all ages receiving either adjuvant, neoadjuvant, or palliative therapies were recruited for the study. All patients were screened for current or previous COVID-19 infection. The participants completed a self-designed COVID-19 pandemic questionnaire, the Stress and Coping Inventory (SCI), the National Comprehensive Cancer Network® (NCCN®) Distress Thermometer (DT), the European Organization for Research and Treatment of Cancer (EORTC) QLQ C30, and the BR23.
RESULTS
RESULTS
Eighty-two breast cancer patients were included. Therapy status and social demographic factors did not have a significant effect on the distress caused by the COVID-19 pandemic. The results of the DT pre and during COVID-19 pandemic did not differ significantly. Using the self-designed COVID-19 pandemic questionnaire, we detected three distinct subgroups demonstrating different levels of concerns in relation to SARS-CoV-2. The subgroup with the highest levels of concern reported significantly decreased life quality, related parameters and symptoms.
CONCLUSIONS
CONCLUSIONS
This monocentric study demonstrated that the COVID-19 pandemic significantly affected psychological health in a subpopulation of breast cancer patients. The application of a self-created "COVID-19 pandemic questionnaire" could potentially be used to help identify breast cancer patients who are susceptible to increased psychological distress due to the COVID-19 pandemic, and therefore may need additional intensive psychological support.
TRIAL REGISTRATION
BACKGROUND
DRKS-ID: DRKS00022507 .
Identifiants
pubmed: 34972520
doi: 10.1186/s12885-021-09012-y
pii: 10.1186/s12885-021-09012-y
pmc: PMC8719114
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1356Informations de copyright
© 2021. The Author(s).
Références
Ann Oncol. 2020 Jul;31(7):894-901
pubmed: 32224151
Soc Sci Med. 1999 Jun;48(11):1507-15
pubmed: 10400253
Lancet Psychiatry. 2014 Oct;1(5):343-50
pubmed: 26360998
Acta Oncol. 2014 Jul;53(7):958-65
pubmed: 24456505
Cancer Nurs. 2001 Jun;24(3):212-9
pubmed: 11409065
J Cancer. 2020 Aug 27;11(21):6243-6247
pubmed: 33033507
J Clin Oncol. 1996 Oct;14(10):2756-68
pubmed: 8874337
Int J Epidemiol. 2014 Apr;43(2):476-93
pubmed: 24648481
Oncology (Williston Park). 1997 Nov;11(11A):109-14; discussion 115-7
pubmed: 9430181
Br J Cancer. 2015 Feb 17;112(4):636-43
pubmed: 25602967
J Clin Oncol. 2018 Mar 10;36(8):780-788
pubmed: 29369731
EJC Suppl. 2013 Sep;11(2):216-24
pubmed: 26217130
Breast Cancer. 2018 Jul;25(4):464-469
pubmed: 29442215
Br J Cancer. 2000 Nov;83(10):1261-7
pubmed: 11044347
Breast Cancer Res Treat. 2017 Jul;164(2):445-450
pubmed: 28444532
J Affect Disord. 2012 Dec 10;141(2-3):343-51
pubmed: 22727334
Nurs Res. 2007 Jan-Feb;56(1):44-53
pubmed: 17179873
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Front Psychol. 2020 Aug 24;11:2033
pubmed: 32982846
Cancer Invest. 2021 Jan;39(1):3-8
pubmed: 33095660
Lancet. 2020 Feb 22;395(10224):e37-e38
pubmed: 32043982
Br J Health Psychol. 2014 Sep;19(3):592-605
pubmed: 23834735
JNCI Cancer Spectr. 2020 Nov 05;5(1):pkaa104
pubmed: 33437925
Breast Cancer Res Treat. 2020 Nov;184(1):249-254
pubmed: 32772225
BMC Cancer. 2012 Aug 03;12:339
pubmed: 22862906
Eur J Cancer Care (Engl). 2005 Mar;14(1):7-15
pubmed: 15698382
BMJ. 2018 Apr 25;361:k1415
pubmed: 29695476
Breast Cancer Res Treat. 2018 Jan;167(1):205-213
pubmed: 28894982
J Natl Cancer Inst. 2018 Dec 1;110(12):1311-1327
pubmed: 30403799
Psychooncology. 2020 Sep;29(9):1395-1398
pubmed: 32596867